HIGHLIGHTS
- who: SUBJECT, AREAS and CANCER, METABOLISM from the Divisions of Interdisciplinary Medicine and Biotechnology, Hematology-Oncology and Nephrology, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Brookline Boston, MA, Metabolite Profiling Initiative, The Broad Institute of MIT and Harvard, Cambridge Center, Cambridge, MA, Center for Regulatory and Environmental Analytical Metabolomics, Department of Chemistry, University of Louisville, Louisville, KY, JG. Brown Cancer Center, University of Louisville, Louisville, KY, . have published the research work: Knockdown of Malic Enzyme 2 Suppresses Lung Tumor Growth, Induces Differentiation and Impacts PI3K/AKT Signaling, in the Journal: (JOURNAL) of 24/06 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.